^
CANCER:
Retinoblastoma
No biomarker
|
Retinoblastoma
|
No biomarker
|
Retinoblastoma
|
cyclophosphamide oral Sensitive: A1 - Approval
|
cyclophosphamide oral Sensitive: A1 - Approval
|
BRD4 overexpression
|
Retinoblastoma
|
BRD4 overexpression
|
Retinoblastoma
|
JQ-1 Sensitive: D – Preclinical
|
JQ-1 Sensitive: D – Preclinical
|
B4GALNT1 expression
|
Retinoblastoma
|
B4GALNT1 expression
|
Retinoblastoma
|
CAR-T immunotherapy Sensitive: D – Preclinical
|
CAR-T immunotherapy Sensitive: D – Preclinical
|
PRMT5 overexpression
|
Retinoblastoma
|
PRMT5 overexpression
|
Retinoblastoma
|
EPZ015666 Sensitive: D – Preclinical
|
EPZ015666 Sensitive: D – Preclinical
|
